title: Functional activity of the cannabinoid 1 receptor is not affected by opioid antagonists in the rat brain.
abstract: BACKGROUND
  WIN55212-2 is a synthetic cannabinoid agonist and selective to cannabinoid 1 (CB1) receptors, which are distributed mainly in the central nervous system. Opioid receptors and CB1 receptors have several similarities in terms of their intracellular signal transduction mechanisms, distributions, and pharmacological action. Several studies have therefore sought to describe the functional interactions between opioids and cannabinoids at the cellular and behavioral levels. The present study investigated agonist-stimulated [(35)S]GTPγS binding by WIN55212-2 in rat brain membranes and determined the antagonism by selective opioid antagonists at the level of receptor-ligand interaction and intracellular signal transduction.
  
  
  METHODS
  Sprague-Dawley rats (male, n = 20) were euthanized for the preparation of brain membranes. In agonist-stimulated [(35)S]GTPγS binding by WIN55212-2, the values of EC50 and maximum stimulation (% over basal) were determined in the absence or presence of the µ, κ and δ opioid receptor antagonists naloxone (20 nM), norbinaltorphimine (3 nM), and naltrindole (3 nM), respectively. Ke values for opioid antagonist inhibition in the absence or presence of each opioid receptor antagonist were calculated using the following equation: [nanomolar antagonist] / (dose ratio of EC50 - 1).
  
  
  RESULTS
  In WIN55212-2-stimulated [(35)S]GTPγS binding in the rat brain membranes, the values of EC50 and maximum stimulation (% over basal) were 154 ± 39.5 nM and 27.6 ± 5.3% over basal, respectively. Addition of selective opioid antagonists did not produce a significant rightward shift in the WIN55212-2 concentration-response curve, and Ke values were not applicable.
  
  
  CONCLUSIONS
  Our results suggest that the functional activity of WIN55212-2-stimulated [(35)S]GTPγS binding was not affected by opioid antagonists in the rat brain membranes. Although the exact mechanism remains unclear, our results may partially elucidate their actions.
authors.affiliation: Department of Anesthesiology and Pain Medicine, School of Medicine, Ewha Womans University, Seoul, Korea.
authors.forename: Heeseung
authors.initials: H
authors.lastname: Lee
keywords: GTP binding; Opioid antagonist; Rat brain; WIN55212-2
references.citation: J Pharmacol Exp Ther. 2005 Feb;312(2):809-15
references.pmid: 15383633
references.citation: Anal Biochem. 1976 May 7;72:248-54
references.pmid: 942051
references.citation: Neuroreport. 1997 Oct 20;8(15):3219-23
references.pmid: 9351646
references.citation: Life Sci. 2006 Jan 2;78(6):549-63
references.pmid: 16109430
references.citation: Neuroreport. 2001 Dec 4;12(17):3689-92
references.pmid: 11726775
references.citation: Cell Signal. 2002 May;14(5):397-405
references.pmid: 11882384
references.citation: Br J Pharmacol. 2006 Jun;148(4):387-95
references.pmid: 16682964
references.citation: Neuropharmacology. 1989 Oct;28(10):1041-6
references.pmid: 2572992
references.citation: Nature. 1998 Sep 24;395(6700):381-3
references.pmid: 9759727
references.citation: Mol Pharmacol. 1995 Apr;47(4):848-54
references.pmid: 7723747
references.citation: Eur J Pharmacol. 1996 Apr 22;301(1-3):75-81
references.pmid: 8773449
references.citation: Neuroscience. 2004;127(1):101-12
references.pmid: 15219673
references.citation: J Pharmacol Exp Ther. 2009 Aug;330(2):567-74
references.pmid: 19448142
references.citation: Eur J Pharmacol. 1994 Jul 21;260(1):5-13
references.pmid: 7957626
references.citation: Pharmacol Biochem Behav. 1998 Jun;60(2):559-66
references.pmid: 9632241
references.citation: Chem Phys Lipids. 2002 Dec 31;121(1-2):83-9
references.pmid: 12505693
references.citation: Trends Pharmacol Sci. 1999 Jul;20(7):287-94
references.pmid: 10390647
references.citation: Neuropharmacology. 2004;47 Suppl 1:345-58
references.pmid: 15464149